Serum Institute of India will begin manufacturing Sputnik V in India

Covishield-maker Serum Institute of India (SII) has decided to manufacture Russia’s Sputnik V over the next two months.

Daily Current Affairs Quiz 2021

SII’s addition to a growing list of Indian partners for Sputnik V would enable the country to churn out over a billion doses of the Russian vaccine every year.

It is also likely to help improve supply of the vaccine in India, where a soft launch has already taken place through vials imported from Russia but doses from most domestic manufacturers are still awaited.

SII, through its partnership with the Russian Direct Investment Fund (RDIF), intends to produce over 300 million doses of Sputnik V per year. This takes India’s annual production capacity of this vaccine to nearly 1.2 billion doses a year.